Ranbaxy, Indian Drugmakers' Estimates Raised at Goldman Sachs

Ranbaxy, Indian Drugmakers' Estimates Raised at Goldman Sachs
Bloomberg - 12 minutes ago
By Shiyin Chen Oct. 14 (Bloomberg) -- Ranbaxy Laboratories Ltd. and eight Indian health-care companies have had their share-price estimates raised by Goldman, Sachs & Co., which cited declining ...